During the past decade, Okayama University Hospital; Respiratory and Allergy Medicine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Okayama University Hospital; Respiratory and Allergy Medicine" are "Non-Squamous Non-Small Cell Lung Cancer" (2 trials), "Cancer" (1 trials), "Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer" (1 trials) and "Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Okayama University Hospital; Respiratory and Allergy Medicine" in a lesser frequency.

Most popular intervention types in "Okayama University Hospital; Respiratory and Allergy Medicine" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Carboplatin" (2 trials), "Docetaxel" (2 trials), "Pemetrexed" (2 trials) and "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Okayama University Hospital; Respiratory and Allergy Medicine" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Okayama University Hospital; Respiratory and Allergy Medicine". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Okayama University Hospital; Respiratory and Allergy Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Okayama University Hospital; Respiratory and Allergy Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".